Kaléo signs first DoD contract for ROCS auto-injectors

Kaléo has executed a contract with the U.S. Department of Defense for the manufacture and delivery of up to 788,000 ROCS auto-injectors, a naloxone antidote for weaponized opioids.

“Kaléo today announced the execution of the first contract with the U.S. Department of Defense (DoD) for the procurement of the Rapid Opioid Countermeasure System (ROCS).”globenewswire.com

• 1 source
• globenewswire.comKaléo Announces First U.S. Department of Defense SupplyKaléoSep 21, 2022

Summarized from public sources; check the original articles before acting on it.